Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

July 01, 2006 (Vol. 26, No. 13)

Spotlighting Neurobiotech Developments

Central Nervous System Remains a Large Target for Novel Therapies

  • The brain is poised to become the number-one target for drug development during the next decade. The neurotechnology market currently exceeds $100 billion, reported Zack Lynch and Casey Crawford Lynch of NeuroInsights (www.neuroinsights.com), publisher of &#34The Neurotechnology Industry 2006 Report&#34. The three sectors of the neurotechnology industry include: neuropharmaceuticals ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.